Literature DB >> 27202489

Cost-Effectiveness of Fecal Microbiota Transplant in Treating Clostridium Difficile Infection in Canada.

H Zowall1, C Brewer1, A Deutsch1.   

Abstract

Entities:  

Year:  2014        PMID： 27202489     DOI： 10.1016/j.jval.2014.08.2512

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  5 in total

1.  Cost-effectiveness of integrating gut microbiota analysis into hospitalisation prediction in cirrhosis.

Authors:  Jasmohan S Bajaj; Chathur Acharya; Masoumeh Sikaroodi; Patrick M Gillevet; Leroy R Thacker
Journal:  GastroHep       Date:  2020-02-06

2.  Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France.

Authors:  Emilie Baro; Tatiana Galperine; Fanette Denies; Damien Lannoy; Xavier Lenne; Pascal Odou; Benoit Guery; Benoit Dervaux
Journal:  PLoS One       Date:  2017-01-19       Impact factor: 3.240

3.  Economic evaluation of Faecal microbiota transplantation compared to antibiotics for the treatment of recurrent Clostridioides difficile infection.

Authors:  Zainab I Abdali; Tracy E Roberts; Pelham Barton; Peter M Hawkey
Journal:  EClinicalMedicine       Date:  2020-06-27

Review 4.  Economic burden and cost-effectiveness of therapies for Clostridiodes difficile infection: a narrative review.

Authors:  Akshita Gupta; Ashwin N Ananthakrishnan
Journal:  Therap Adv Gastroenterol       Date:  2021-05-30       Impact factor: 4.409

Review 5.  Cost-Effectiveness of Fecal Microbiota Transplantation in the Treatment of Recurrent Clostridium Difficile Infection: A Literature Review.

Authors:  Leor T Arbel; Edmund Hsu; Keegan McNally
Journal:  Cureus       Date:  2017-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.